Organizing Committee

Dr. Singer is a graduate of the University of California in San Francisco School of Medicine and trained in internal medicine at the Wadsworth Veterans Administration Center in Los Angeles. Endocrinology fellowships were done at the Massachusetts General Hospital in Boston and at the Royal Postgraduate Medical School in London. He was also a Clinical Investigator at the Wadsworth Veterans Administration Medical Center. He then moved to the faculty of the University of Southern California for 15 years, spent 4 years at Cedars Sinai Medical Center in Los Angeles and for the past 29 years has been in the Endocrine/Bone disease Program at the John Wayne Cancer Institute at Providence Saint Johns Health Center in Santa Monica. He is a clinical professor of medicine at the David Geffen School of Medicine at UCLA. His research interests have been Paget’s disease of bone, osteoporosis, and primary hyperparathyroidism. He is a past president of the American Society for Bone and Mineral Research and a board member of the National Osteoporosis Foundation.

Dr. Singer is a graduate of the University of California in San Francisco School of Medicine and trained in internal medicine at the Wadsworth Veterans Administration Center in Los Angeles. Endocrinology fellowships were done at the Massachusetts General Hospital in Boston and at the Royal Postgraduate Medical School in London. He was also a Clinical […]

Dr. Limin Chen, a professor with Chinese Academy of Medical Sciences (CAMS)/Peking Union Medical College (PUMC) and also an affiliate scientist with the University of Toronto, Canada，now is the director and chief scientific officer of the center for transfusion transmitted infectious diseases, Institute of Blood Transfusion (IBT), CAMS/PUMC, Member of the American Association for Studies of Liver Diseases (AASLD) and Canadian Association for Studies of Liver (CASL). He got his MD, MSc in biochemistry and molecular biology in China, PhD in molecular genetics at the University of Toronto. Dr. Chen obtained his postdoctoral training both at Merck Research Laboratories (West Point, PA) and at the Harvard Medical School (MGH) . Currently Dr. Chen’s research focuses on the virus-host interaction of the transfusion-transmitted viruses, especially on HCV and HBV and emerging vuruses. He pioneered the work on identification of the response signature and proposed a novel mechanism on how HCV/HBV exploits host innate immune response to benefit its persistent infection and resistance to interferon-based therapy.

Dr. Limin Chen, a professor with Chinese Academy of Medical Sciences (CAMS)/Peking Union Medical College (PUMC) and also an affiliate scientist with the University of Toronto, Canada，now is the director and chief scientific officer of the center for transfusion transmitted infectious diseases, Institute of Blood Transfusion (IBT), CAMS/PUMC, Member of the American Association for Studies […]